Cargando…
Multicentre, non-interventional study of the efficacy and tolerability of linaclotide in the treatment of irritable bowel syndrome with constipation in primary, secondary and tertiary centres: the Alpine study
OBJECTIVES: We evaluated the effectiveness and tolerability of linaclotide, a minimally absorbed guanylate cyclase-C agonist, in patients with irritable bowel syndrome with constipation (IBS-C) in routine clinical practice. SETTING: A multicentre, non-interventional study conducted between December...
Autores principales: | Pohl, Daniel, Fried, Michael, Lawrance, Dominic, Beck, Elmar, Hammer, Heinz F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955540/ https://www.ncbi.nlm.nih.gov/pubmed/31892640 http://dx.doi.org/10.1136/bmjopen-2018-025627 |
Ejemplares similares
-
IMAGINE Network’s Mind And Gut Interactions Cohort (MAGIC) Study: a protocol for a prospective observational multicentre cohort study in inflammatory bowel disease and irritable bowel syndrome
por: Moayyedi, Paul, et al.
Publicado: (2020) -
UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation
por: Yiannakou, Yan, et al.
Publicado: (2018) -
Review article: linaclotide for the management of irritable bowel syndrome with constipation
por: Layer, P, et al.
Publicado: (2014) -
Assessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome – IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial
por: Kerckhove, Nicolas, et al.
Publicado: (2017) -
Meditation and yoga for irritable bowel syndrome: study protocol for a randomised clinical trial (MY-IBS study)
por: D'Silva, Adrijana, et al.
Publicado: (2022)